BLR&D Research Career Scientist Award Application
BLR
基本信息
- 批准号:10516025
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-10-01 至 2025-09-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdministrative SupplementAffectAmericanAmerican Heart AssociationAnimal ModelAnimalsAppointmentAwardBiologyBlood VesselsBlood flowBrainBrain DiseasesCardiometabolic DiseaseCardiovascular DiseasesCerebrovascular DisordersCerebrovascular systemCerebrumChronicCoagulation ProcessCollaborationsComplications of Diabetes MellitusDementiaDiabetes MellitusDiseaseDisease modelEndocrinologyExtramural ActivitiesFailureFemaleFundingGrantHealthcareHypertensionImpaired cognitionImpairmentInjuryInterventionIschemic Brain InjuryIschemic Neuronal InjuryIschemic StrokeJournalsMentorsMicrovascular DysfunctionMissionMolecularNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Neurological Disorders and StrokeNeuronsPaperPathologicPatientsPatternPericytesPharmaceutical PreparationsPharmacologyPhysiologyPostdoctoral FellowProcessProgram Research Project GrantsPublicationsPublishingQuality of lifeRecoveryRecovery of FunctionResearchResearch PersonnelRiskRisk FactorsRoleScientistSenior ScientistSocietiesStrokeStructureSystemTrainingTraining ProgramsUnited States Department of Veterans AffairsUnited States National Institutes of HealthUniversitiesVeteransWagesWomen&aposs Healthacute strokearterioleblood vessel occlusionbrain dysfunctionbrain repaircareercognitive recoverydementia riskdiabeticdisabilityimprovedinnovationjuvenile animalmalemilitary veteranmultidisciplinaryneovascularizationnext generationpeerpost strokepost stroke cognitive impairmentpost stroke dementiaprofessorprogramsrepairedsexstroke patientstroke recoverystroke therapysuccessvascular injuryvascular risk factorworking group
项目摘要
Stroke is the number one cause of disability in the US. This is a result of physical impairments as well as
increased risk of dementia after stroke. High blood pressure is the top risk factor for stroke followed by
diabetes. High blood pressure, diabetes and stroke are highly prevalent in our Veterans. Hypertension is the
most common vascular risk factor among Veterans with stroke. Moreover, among Veterans, hypertension is
the most common chronic condition, affecting more than 37% of the Veteran population. 25% of our Veterans
have diabetes. Despite years of extensive research, all efforts to protect neurons from ischemic stroke injury
failed. There is only one treatment for stroke and that is to open the occluded blood vessels with a clot-busting
drug. There is NO treatment for dementia that develops after stroke. Reasons for this failure may be several
fold: 1) researchers have used otherwise healthy and young animal models in research; 2) most studies
utilized male animals; and 3) researchers have tried to salvage and repair only "neurons". It is now increasingly
recognized that blood vessels of the brain are extremely critical for the acute stroke injury and chronic
recovery. When blood flow to the brain is compromised, cognitive impairment ensues and recovery from stroke
is impaired. Targets for new treatments may be different in females and/or diseases like diabetes and high
blood pressure that are commonly found in patients with stroke or cognitive impairment. This is also quite
relevant to VA mission as our female Veterans are steadily increasing among our Veterans and suffering from
these diseases necessitating the VA to launch the “Women’s Health Initiative”. Dr. Ergul, a well-accomplished
VA Research Career Scientist and Regents’ Professor at Augusta University, uses her uniquely combined
expertise in endocrinology, physiology, pharmacology and vascular biology to address these gaps by studying
the interaction of diabetes and high blood pressure with associated complications such as stroke and cognitive
impairment in both sexes. She is extremely committed to improve the quality of life of our Veterans and our
society, a commitment solidified by Research Career Scientist recognition in the last 5 years. Her commitment
to VA and cardiovascular disease research is evidenced by 1) continuous extramural finding by National
Institutes of Health, American Heart Association, American Diabetes Association, and Veterans Affairs in the
last 20 years, 2) her over 150 publications (59 alone during the tenure of the RCS in the last 5 years), 3)
success of renewing VA Merit Award twice during the current RCS award period, 4) receiving additional
extramural funding to address complementary scientific questions, 5) her stature as a leader in the field and 6)
the success of her mentoring next generation of scientists.
在美国,中风是导致残疾的头号原因。这是身体损伤的结果,以及
中风后患痴呆症的风险增加。高血压是中风的首要危险因素,其次是
糖尿病。高血压、糖尿病和中风在我们的退伍军人中非常普遍。高血压是最重要的
中风退伍军人中最常见的血管危险因素。此外,在退伍军人中,高血压是
最常见的慢性疾病,影响了37%以上的退伍军人。25%的退伍军人
得了糖尿病。尽管多年来进行了广泛的研究,但所有保护神经元免受缺血性中风损伤的努力
失败了。中风的治疗方法只有一种,那就是用溶栓法打开闭塞的血管。
毒品。中风后出现的痴呆症没有治疗方法。导致这一失败的原因可能有几个
折叠:1)研究人员在研究中使用了其他健康和年轻的动物模型;2)大多数研究
利用雄性动物;3)研究人员试图仅抢救和修复“神经元”。现在越来越多的人
认识到脑血管对急性卒中损伤和慢性脑损伤极为重要
恢复。当流向大脑的血液受到损害时,认知障碍就会随之而来,中风就会恢复。
是受损的。新治疗的目标可能在女性和/或糖尿病和高血压等疾病中有所不同
通常在中风或认知障碍患者中发现的血压。这也是相当的
与退伍军人使命相关,因为我们的女性退伍军人在退伍军人中稳步增加,并遭受
这些疾病促使退伍军人事务部发起“妇女健康倡议”。厄格尔博士,一位学识渊博的
弗吉尼亚州研究职业科学家和奥古斯塔大学的董事教授,使用她独特的组合
在内分泌学、生理学、药理学和血管生物学方面的专业知识,通过研究来填补这些差距
糖尿病和高血压与中风和认知等相关并发症的相互作用
两种性别都有损害。她非常致力于改善我们退伍军人和我们的
社会,这一承诺在过去5年里得到了研究职业科学家的认可。她的承诺
对退伍军人事务部和心血管疾病的研究被1)国家大学不断的校外发现所证明
卫生研究院、美国心脏协会、美国糖尿病协会和退伍军人事务部
最近20年,2)她发表了150多篇出版物(仅在过去5年的RCS任期内就发表了59篇),3)
在当前RCS获奖期内成功续签两次VA优异奖,4)获得额外
解决互补科学问题的外部资金,5)她作为该领域领导者的地位和6)
她成功地指导了下一代科学家。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ADVIYE ERGUL其他文献
ADVIYE ERGUL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ADVIYE ERGUL', 18)}}的其他基金
ShEEP Request for Noldus EthoVision XT System
ShEEP 请求 Noldus EthoVision XT 系统
- 批准号:
10534037 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Progressive Post Stroke Cognitive Impairment:Mechanisms & Intervention
进行性中风后认知障碍:机制
- 批准号:
10237897 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Progressive Post Stroke Cognitive Impairment:Mechanisms & Intervention
进行性中风后认知障碍:机制
- 批准号:
10468083 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Progressive Post Stroke Cognitive Impairment:Mechanisms & Intervention
进行性中风后认知障碍:机制
- 批准号:
10011890 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Vascular Injury and Recovery in Diabetic Ischemic Stroke
糖尿病缺血性中风的血管损伤和恢复
- 批准号:
9429297 - 财政年份:2017
- 资助金额:
-- - 项目类别:
Vascular Injury and Recovery in Diabetic Ischemic Stroke
糖尿病缺血性中风的血管损伤和恢复
- 批准号:
10541346 - 财政年份:2014
- 资助金额:
-- - 项目类别:
Vascular Injury and Recovery in Diabetic Ischemic Stroke
糖尿病缺血性中风的血管损伤和恢复
- 批准号:
9217676 - 财政年份:2014
- 资助金额:
-- - 项目类别:
Vascular Injury and Recovery in Diabetic Ischemic Stroke
糖尿病缺血性中风的血管损伤和恢复
- 批准号:
8848660 - 财政年份:2014
- 资助金额:
-- - 项目类别:
相似海外基金
Proton-secreting epithelial cells as key modulators of epididymal mucosal immunity - Administrative Supplement
质子分泌上皮细胞作为附睾粘膜免疫的关键调节剂 - 行政补充
- 批准号:
10833895 - 财政年份:2023
- 资助金额:
-- - 项目类别:
A Longitudinal Qualitative Study of Fentanyl-Stimulant Polysubstance Use Among People Experiencing Homelessness (Administrative supplement)
无家可归者使用芬太尼兴奋剂多物质的纵向定性研究(行政补充)
- 批准号:
10841820 - 财政年份:2023
- 资助金额:
-- - 项目类别:
StrokeNet Administrative Supplement for the Funding Extension
StrokeNet 资助延期行政补充文件
- 批准号:
10850135 - 财政年份:2023
- 资助金额:
-- - 项目类别:
2023 NINDS Landis Mentorship Award - Administrative Supplement to NS121106 Control of Axon Initial Segment in Epilepsy
2023 年 NINDS 兰迪斯指导奖 - NS121106 癫痫轴突初始段控制的行政补充
- 批准号:
10896844 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Biomarkers of Disease in Alcoholic Hepatitis Administrative Supplement
酒精性肝炎行政补充剂中疾病的生物标志物
- 批准号:
10840220 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Administrative Supplement: Life-Space and Activity Digital Markers for Detection of Cognitive Decline in Community-Dwelling Older Adults: The RAMS Study
行政补充:用于检测社区老年人认知衰退的生活空间和活动数字标记:RAMS 研究
- 批准号:
10844667 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Administrative Supplement: Improving Inference of Genetic Architecture and Selection with African Genomes
行政补充:利用非洲基因组改进遗传结构的推断和选择
- 批准号:
10891050 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Power-Up Study Administrative Supplement to Promote Diversity
促进多元化的 Power-Up 研究行政补充
- 批准号:
10711717 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Administrative Supplement for Peer-Delivered and Technology-Assisted Integrated Illness Management and Recovery
同行交付和技术辅助的综合疾病管理和康复的行政补充
- 批准号:
10811292 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Administrative Supplement: Genome Resources for Model Amphibians
行政补充:模型两栖动物基因组资源
- 批准号:
10806365 - 财政年份:2023
- 资助金额:
-- - 项目类别:














{{item.name}}会员




